A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy

Stopped early · Early Phase 1

Conditions studied: Head and Neck Cancer

In brief

Patients with head and neck cancer and are schedule to receive standard radiation therapy known as IMRT to treat cancer

Key facts

Study ID

NCT00608751

Run by

Washington University School of Medicine

People needed

5

Starts

2007-01-01

Expected to finish

2008-01-01

Last updated by the study team

2013-05-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age >= 18
• Karnofsky Performance Status of >= 60
• New diagnosis of head-and-neck cancer, all subsites included (i.e. nasopharynx, oropharynx, oral cavity, hypopharynx, larynx.)
• All stages with measurable gross disease (>= 1.0 cm) by CT imaging
• Pathologic confirmation of squamous cell carcinoma by biopsy or cytology
• Signed study-specific consent form
• Sequential or concurrent chemotherapy is allowed but not mandated. (no chemotherapy is allowed if patient is judged not to be a candidate for chemotherapy by the medical oncologist)

You may not qualify if…

• Age < 18
• Karnofsky Performance Status < 60
• Radiographic or pathologic evidence of distant metastatic disease (i.e. other than cervical lymph nodes)
• Prior radiation therapy to the head-and-neck region

Where it is running

• Washington University School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.